Hepatitis B viral infection

Clinical trials for Hepatitis B viral infection explained in plain language.

Never miss a new study

Get alerted when new Hepatitis B viral infection trials appear

Sign up with your email to follow new studies for Hepatitis B viral infection, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Terminated 1

Hepatitis b drug combo tested in phase 3 trial – but study stopped early

Disease control Stopped early

This study tested two antiviral drugs, clevudine and tenofovir, alone or together, in 150 adults with chronic hepatitis B who had not been treated before. The goal was to see which approach worked best at controlling the virus after 96 weeks of treatment and 24 weeks of follow-up…

Matched conditions: HEPATITIS B VIRAL INFECTION

Phase 3 • Sponsor: French National Agency for Research on AIDS and Viral Hepatitis • Aim: Disease control

Last updated Jun 27, 2026 12:04 UTC

Hepatitis B viral infection

Get alerted when new Hepatitis B viral infection trials appear

Hepatitis b drug combo tested in phase 3 trial – but study stopped early